Canada Post Corp Registered Pension Plan boosted its position in shares of Humana Inc. (NYSE:HUM – Free Report) by 142.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,849 shares of the insurance provider’s stock after acquiring an additional 2,851 shares during the quarter. Canada Post Corp Registered Pension Plan’s holdings in Humana were worth $1,238,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently bought and sold shares of HUM. Elevation Point Wealth Partners LLC purchased a new stake in Humana during the 2nd quarter worth approximately $32,000. Mather Group LLC. acquired a new position in shares of Humana in the third quarter worth $34,000. AlphaCore Capital LLC acquired a new position in shares of Humana in the second quarter worth $39,000. Private Wealth Management Group LLC increased its position in shares of Humana by 47.5% during the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after acquiring an additional 48 shares during the period. Finally, SJS Investment Consulting Inc. raised its stake in shares of Humana by 19,300.0% in the third quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock valued at $50,000 after acquiring an additional 193 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
HUM has been the subject of several analyst reports. Sanford C. Bernstein reissued an “outperform” rating and set a $344.00 target price on shares of Humana in a research note on Tuesday, January 6th. Zacks Research cut Humana from a “hold” rating to a “strong sell” rating in a research note on Thursday, January 1st. Morgan Stanley reissued an “underperform” rating on shares of Humana in a research report on Thursday, December 18th. Barclays restated an “underperformer” rating on shares of Humana in a research note on Monday, January 5th. Finally, Wolfe Research lifted their price target on shares of Humana from $300.00 to $325.00 and gave the stock an “outperform” rating in a research note on Thursday, January 8th. Eight research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $293.21.
Humana Price Performance
HUM stock opened at $193.91 on Friday. The business has a 50 day moving average price of $251.55 and a 200 day moving average price of $262.86. The stock has a market cap of $23.32 billion, a price-to-earnings ratio of 18.17, a PEG ratio of 1.61 and a beta of 0.44. Humana Inc. has a fifty-two week low of $186.00 and a fifty-two week high of $315.35. The company has a quick ratio of 2.02, a current ratio of 2.02 and a debt-to-equity ratio of 0.68.
Humana (NYSE:HUM – Get Free Report) last announced its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, beating the consensus estimate of $2.95 by $0.29. The company had revenue of $32.65 billion for the quarter, compared to analyst estimates of $31.99 billion. Humana had a net margin of 1.02% and a return on equity of 12.86%. The firm’s revenue was up 11.1% on a year-over-year basis. During the same period in the prior year, the firm posted $4.16 earnings per share. Equities research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Further Reading
- Five stocks we like better than Humana
- The buying spree that no one is talking about
- Virtually Limitless Energy
- The $650 Million Bet on AI’s Future
- The gold chart Wall Street is terrified of…
- NEW LAW: Congress Approves Setup For Digital Dollar?
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
